[Results] 61 weeks on 1.7mg, full numbers, ask me anything boring
I have had 23 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 24 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 98.4% against a claimed 97.2%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
API transparency is the question that separates good compounders from sketchy ones
Disagree but this is the good kind of wrong — it is specific enough to be checked.
API source questions are on-topic and compounders dodging them is newsworthy
API source questions are on-topic and compounders dodging them is newsworthy
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
Strongly agree. API source transparency matters.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
[deleted]
regulatory claims need a citation to the actual rule, not interpretation
state board rules differ, say which state
Strongly agree. API source transparency matters.
Respectfully this is a sample of one presented as a finding.
API source questions are on-topic and compounders dodging them is newsworthy
no pharmacy referral codes, naming is fine, recruiting is not
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the 503A/503B distinction is load-bearing, do not blur it
API transparency is the question that separates good compounders from sketchy ones
the 503A/503B distinction is load-bearing, do not blur it
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
API transparency is the question that separates good compounders from sketchy ones
Strongly agree. API source transparency matters.
telehealth costs telehealth plus compounding markup, total varies
This is the "correlation is mechanism" thing again. You changed three variables at once.
telehealth costs API source plus compounding markup, total varies
the 503A/503B distinction is load-bearing, do not blur it
The confident tone is doing a lot of work that the evidence is not.
This is correct. The shortage list does expire and the rules change.
- 1Inter-lab variance on this kind of assay is routinely 1–2 points. Different…12 comments in this branch · started by u/elin_ferrari
- 2good post. terrible flair.7 comments in this branch · started by u/nadia_fonseca